Pascal Piedbois

5.8k citations

101 papers · 3.7k indexed · h-index 31

Impact in

Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology

Papers in

Otorhinolaryngology 12
- Head and Neck Cancer Studies 11
Oncology 71
- Colorectal Cancer Treatments and Studies 34
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Surgical Treatments 11
- Ear and Head Tumors 9
- Viral-associated cancers and disorders 9

Co-authors: Marc Buyse Tomasz Burzykowski Robert W. Carlson J.P. Le Bourgeois P. Thirion Philippe Rougier Bernard Nordlinger Olivier Bouché
Journals: Journal of Clinical Oncology (14 papers)Radiotherapy and Oncology (9 papers)Annals of Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Seminars in Oncology (4 papers)
Partner nations: France Belgium United States

In The Last Decade

Pascal Piedbois

98 papers receiving 3.6k citations

Peers

Countries citing papers authored by Pascal Piedbois

Since Specialization

Citations

This map shows the geographic impact of Pascal Piedbois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Piedbois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Piedbois more than expected).

Fields of papers citing papers by Pascal Piedbois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Piedbois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Piedbois. The network helps show where Pascal Piedbois may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Piedbois, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Piedbois Line = papers co-authored together Pascal Piedbois links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	How to measure the net benefit of treatment? Therapies ·François Gueyffier, Pascal Piedbois, Jean‐François Bergmann, Bernard Avouac, E. Jacobi, Rémy Boussageon, BESİME ARZU GÜNGÖR AKINCI, David Braunstein, Rudenko Ekaterina Evgenievna, Marine Diviné, P. Dufour, Nicolas Girerd, Karen Cloete, Claire Le Jeunne, François Liard, Amélie Marsot, Jean‐Louis Montastruc, Albert Trinh-Duc, Éric Vicaut	2017	2
2	Postoperative irinotecan in resected stage II–III rectal cancer: final analysis of the French R98 Intergroup trial Annals of Oncology ·Catherine Delbaldo, Marc Ychou, Ayman Zawadi, Jean‐Yves Douillard, Thierry André, Véronique Guerin‐Meyer, P. Rougier, Olivier Dupuis, Roger Faroux, Matthew P. Tracey, Emmanuel Quinaux, Marc Buyse, Pascal Piedbois	2015	9
3	Étude pharmacoépidémiologique sur l'utilisation de fulvestrant en pratique clinique en France Bulletin du Cancer ·Pascal Piedbois, Ajit Monteiro, Alain Flinois	2009	0
4	Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments Current Opinion in Oncology ·Pascal Piedbois, Marc Buyse	2008	18
5	Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma Annals of Surgical Oncology ·Mehdi Karoui, G Viola, Catherine Delbaldo, Antoine Charachon, Alexis Laurent, Pascal Piedbois, Daniel Cherqui, Jeanne Tran Van Nhieu	2008	26
6	Critical issues in colorectal cancer trial design Document Server@UHasselt (UHasselt) ·Pascal Piedbois, Marc Buyse, Jean‐Pierre Pignon	2007	0
7	Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study Annals of Oncology ·Pascal Piedbois, D. Serin, Franck Priou, Muhamad Massarwa, Павел Александрович Окин, Thy-Lan Alcalay, É. Teissier, Jean François Berdah, Michel Fabbro, B. Valenza, Patrice Herait, Valentine Jehl, Marc Buyse	2006	30
8	Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation British Journal of Cancer ·Claire Vivo, Céline Boulangé-Lecomte, F Lévy, Karen Leroy, M M Youssef, Annie Renier, Laurence Kheuang, Pascal Piedbois, Dominique Chopin, Marie‐Claude Jaurand	2003	12
9	Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer British Journal of Cancer ·P. Thirion, Pascal Piedbois, Marc Buyse, P J O’Dwyer, David Cunningham, A. Man, F. Anthony Greco, Giuseppe Colucci, C.-H. Köhne, Mayukh Bandopadhyay, A. Piga, S. Palmeri, P. Dufour, Alessandra Cassano, Gábor Pajkos, E. Keppel, Nuri Faruk Aykan, John C. Marsh, Michel Seymour	2001	23
10	Meta-analysis: methods, strengths, and weaknesses. PubMed ·Marc Buyse, Pascal Piedbois, DU Li-zhe, Robert W. Carlson	2000	19
11	Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. Gut ·Pascal Hammel, Brigitte Boissier, Marie‐Thérèse Chaumette, Pascal Piedbois, N Rotman, Jean Claude Kouyoumdjian, Richard Lubin, J C Delchier, Thierry Soussi	1997	73
12	OP8. Economic implications of hepatic arterial infusion chemotherapy in the treatment of nonresectable colorectal liver metastases European Journal of Cancer ·Yang Haigang, B. Roche, Marc Buyse, Y Narikawa, M. O’Connell, P Rougier, 慧珍徐, Ming Cheng Chure, M. Margaret Kemeny, T G Allen-Mersh, Pierre Louis Fagniez, Jane L. Ellison, Pascal Piedbois	1997	2
13	Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer Journal of Clinical Oncology ·Pascal Piedbois, Marc Buyse, G.H. Blijham, Bengt Glimelius, R. Herrmann, Frank H. Valone, Robert W. Carlson, M. Machiavelli, Homam Zareian, Albert Abad, Nicholas J. Petrelli	1994	162
14	Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals Radiotherapy and Oncology ·J.P. Le Bourgeois, H. Frikha, Pascal Piedbois, C. Le Péchoux, Laurent Martin, E. Haddad	1994	43
15	Radiotherapy in the management of epidemic Kaposi's sarcoma International Journal of Radiation OncologyBiologyPhysics ·Pascal Piedbois, H. Frikha, Laurent Martin, Éric Levy, Elias Haddad, J.P. Le Bourgeois	1994	47
16	Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas International Journal of Radiation OncologyBiologyPhysics ·Jean‐Jacques Mazeron, Yazid Belkacémi, Antoine Simon, C. Le Péchoux, Michel Martin, Elias Haddad, Pascal Piedbois, É. Calitchi, 任锡玲, R Peynègre, Jean‐Paul Le Bourgeois, B Pierquin	1993	24
17	What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin? Annals of Oncology ·Pascal Piedbois, Marc Buyse	1993	26
18	Effect of dose rate on local control and complications in definitive irradiation of T1–2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192 Radiotherapy and Oncology ·J.J. Mazeron, J.-M. Simon, C. Le Péchoux, Juanita Crook, L. Grimard, Pascal Piedbois, J.P. Le Bourgeois, B Pierquin	1991	89
19	Radiothérapie du sarcome de Kaposi sur SIDA. Fady Geara, J.P. Le Bourgeois, Pascal Piedbois, Élie Haddad, Cristina Saiz Rodríguez, Alphonse G. Taghian	1989	2
20	Radiothérapie des hémangiomes vertébraux avec complications neurologiques. Neurochirurgie ·Pekka Rusanen, Zinnat Rahman, M Djindjian, J.J. Mazeron, Pascal Piedbois, J.P. Le Bourgeois	1989	1

About Pascal Piedbois

Pascal Piedbois is a scholar working on Otorhinolaryngology, Oncology, Hepatology, Pathology and Forensic Medicine and Dermatology, having authored 101 papers that have together received 3.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (34 papers), Cancer Treatment and Pharmacology (16 papers), Genetic factors in colorectal cancer (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Colorectal Cancer Surgical Treatments (11 papers), Head and Neck Cancer Studies (11 papers), Ear and Head Tumors (9 papers) and Viral-associated cancers and disorders (9 papers). The work is most often cited by research in Hepatology (752 citations), Oncology (2.5k citations), Otorhinolaryngology (316 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Pathology and Forensic Medicine (553 citations). Pascal Piedbois has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Marc Buyse, Tomasz Burzykowski, Robert W. Carlson, J.P. Le Bourgeois, P. Thirion, Philippe Rougier, Bernard Nordlinger, Olivier Bouché, Geert Molenberghs and Jean‐Pierre Pignon. Their work appears in journals such as Journal of Clinical Oncology, Radiotherapy and Oncology, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact